DesboisACValletHDomontFComarmondCCacoubPSaadounD. Management of severe complications in Behçet’s disease with TNF inhibitors. Expert Opin Biol Ther. 2017;17(7):853-859. doi:10.1080/14712598.2017.1328496
2.
SaadounDBodaghiBCacoubP. Behçet’s syndrome. N Engl J Med. 2024;390(7):640-651. doi:10.1056/NEJMra2305712
3.
Kural-SeyahiEFreskoISeyahiN, et al. The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore). 2003;82(1):60-76. doi:10.1097/00005792-200301000-00006
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.